StockTipsArenaBeta

BUY IPCA Laboratories Limited — Deven Mehata, IDBI Capital Markets and Securities

BUYIPCA Laboratories Limited
IPCA Laboratories share price target & all analyst calls

byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: Swing (≤2wk)21 Sept 2026via NDTV Profit (Live)

Entry₹2,012Inferred
Target₹2,150
Total upside +6.86% (call closed)
Stop loss₹1,940-3.58% risk
Exit₹1,94028 Sept 2026, 9:50 am
Stop-loss hit-3.58%
Follow Deven Mehata for new calls(17% target hit, 92 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Sept 2026
3 supporting0 opposing
Supports the BUY call (3)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·17 Sept · 1w ago

Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits

NewsGoogle News·16 Sept · 2w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·18 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IPCA Laboratories

All analyst calls on IPCA Laboratories

More from Deven Mehata, IDBI Capital Markets and Securities

Every call and its outcome